Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

Bafilomycin A1 activates USP15. 2 / 2

| 2

➶

reach

"Remarkably, the band intensity of p24 by USP15 was visibly weaker, when the cells were treated with Bafilomycin A1 (compare p24 intensity in XREF_FIG with A), indicating that endosomal degradation inhibitor actually accelerated p24 degradation by unknown mechanism."

27460547

➶

reach

"Remarkably, the band intensity of p24 by USP15 was visibly weaker, when the cells were treated with Bafilomycin A1 (compare p24 intensity in Fig. 8 C with A), indicating that endosomal degradation inh[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

27460547

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...